2022
DOI: 10.3389/fmolb.2021.783644
|View full text |Cite
|
Sign up to set email alerts
|

Mucopolysaccharidosis Type I in the Russian Federation and Other Republics of the Former Soviet Union: Molecular Genetic Analysis and Epidemiology

Abstract: Mutations in the IDUA gene cause deficiency of the lysosomal enzyme alpha-l-iduronidase (IDUA), which leads to a rare disease known as mucopolysaccharidosis type I. More than 300 pathogenic variants of the IDUA gene have been reported to date, but not much is known about the distribution of mutations in different populations and ethnic groups due to the low prevalence of the disease. This article presents the results of a molecular genetic study of 206 patients with mucopolysaccharidosis type I (MPS I) from th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(13 citation statements)
references
References 53 publications
0
13
0
Order By: Relevance
“…Missense/nonsense mutations accounted for the highest proportion, other mutation types were splice site mutations, deletions, and insertions, and complex rearrangements. 9 However, the association between genotype and phenotype is unclear due to differences in genetic polymorphism and environmental factors. Current treatment options for MPS I include hematopoietic stem cell transplantation (HSCT), enzyme replacement therapy (ERT), or a combination of both therapies.…”
Section: Discussionmentioning
confidence: 99%
“…Missense/nonsense mutations accounted for the highest proportion, other mutation types were splice site mutations, deletions, and insertions, and complex rearrangements. 9 However, the association between genotype and phenotype is unclear due to differences in genetic polymorphism and environmental factors. Current treatment options for MPS I include hematopoietic stem cell transplantation (HSCT), enzyme replacement therapy (ERT), or a combination of both therapies.…”
Section: Discussionmentioning
confidence: 99%
“…There are currently thirteen MPSs that have been identified, and two of them were found in the 2020s [ 1 ]. Mucopolysaccharidosis type I (MPS I) is a rare inherited autosomal recessive lysosomal storage disorder caused by pathogenic α-L-iduronidase (IDUA) gene variant mutations, resulting in a deficiency of IDUA activity [ 1 , 2 ]. The IDUA gene has 14 exons and 13 introns and is found on chromosome 4 at location 4p16.3 [ 1 , 2 , 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Mucopolysaccharidosis type I (MPS I) is a rare inherited autosomal recessive lysosomal storage disorder caused by pathogenic α-L-iduronidase (IDUA) gene variant mutations, resulting in a deficiency of IDUA activity [ 1 , 2 ]. The IDUA gene has 14 exons and 13 introns and is found on chromosome 4 at location 4p16.3 [ 1 , 2 , 3 , 4 ]. There have been >300 reported variants of IDUA in the Human Genetic Mutation Database, the majority of which are missense/nonsense mutations [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Copy number variations have been also reported [ 10 ]. The most common causative variants reported worldwide include c.1205G > A (p.Trp402Ter), c.208C > T (p.Gln70Ter), c.1598C > G (p.Pro533Arg), and c.152G > A (p.Gly51Asp) [ 2 , 11 , 12 ]. c.1205G > A accounts for approximately 45% of disease alleles in the United States, whereas c.208C > T is mostly recorded in Russia and Scandinavia with a 50% frequency [ 2 , 13 , 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%